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an essential role in transmitting information on influenza 
vaccination in pregnant women and has a significant impact 
on uptake.
Keywords: Influenza, Pregnancy, Immunization, Vaccine coverage, Vaccina-
tion uptake, Midwife, Health professionals.
Vacunación de mujeres embarazadas en la 
Comunidad Valenciana durante la temporada 
de gripe 2014-15: un estudio multicéntrico 
RESUMEN
Objetivos. Investigar la cobertura de la vacunación 
antigripal en gestantes en tres Departamentos de Salud de 
la Comunidad Valenciana (España) durante la temporada 
2014-15, y evaluar su aceptabilidad, fuentes de información y 
motivos de rechazo hacia la inmunización contra la gripe.
Métodos. Estudio descriptivo transversal multicéntrico 
en la campaña vacunal 2014-15. La cobertura vacunal se 
identificó a través del Registro Nominal de Vacunas (RVN). 
Posteriormente, se realizaron 2 encuestas telefónicas a un 
mínimo muestral de puérperas vacunadas y no vacunadas. 
Resultados. De 1.569 puérperas, 934 (59,5%) disponen de 
información en el RVN; la distribución por Departamentos: 420 
(44,9%), 161 (17,2%) y 353 (37,8%) en La Ribera, Torrevieja 
y Elx-Crevillent respectivamente. Se obtuvo una cobertura 
vacunal del 27,9% (n=261). Según la variable “País de Origen”, 
el 77,5% (n=724) es española, con una tasa vacunal del 26,7% 
(n=193), frente al 22,5% (n=210) extranjera, con el 32,4% 
(n=68). La principal fuente de información fue la matrona en 
el 83,7% (n=159) de gestantes vacunadas y el 44,6% (n=127) 
en no vacunadas. Los principales motivos de rechazo fueron 
el desconocimiento (29,5%; n=84) y el no considerarse 
imprescindible (25,6%; n=73).
Conclusiones. A pesar de su alta predisposición a 
ABSTRACT
Background. To study influenza vaccination uptake 
in pregnant women from three Health Departments in the 
Valencian Community (Spain) during the 2014-15 flu season, 
to identify degree of knowledge, sources of information and 
attitudes toward immunization against influenza.
Methods. Multicentre cross-sectional descriptive study 
during the 2014-15 vaccination campaign. Vaccine coverage 
was determined using the Nominal Vaccination Registry (NVR). 
Subsequently, a telephone survey was carried out on a sample 
of vaccinated and unvaccinated postpartum women.
Results. The NVR had information on 934 (59.5%) 
out of 1,569 postpartum women; distribution per Health 
Departments was: 420 (44.9%), 161 (17.2%) and 353 (37.8%) 
in La Ribera, Torrevieja and Elx-Crevillent respectively. Vaccine 
uptake was 27.9% (n = 261). According to the “Country of 
Origin” variable, 77.5% (n = 724) of women were Spanish, with 
a vaccination rate of 26.7% (n = 193), compared to 22.5% (n = 
210) who were non-Spanish, with a rate of 32.4% (n = 68). The 
main source of information was midwives for 83.7% (n = 159) 
of vaccinated pregnant women and for 44.6% (n = 127) of 
non-vaccinated women. The main reasons for vaccine refusal 
were lack of awareness (29.5%, n = 84) and not considering it 
necessary (25.6%, n = 73).
Conclusion. Despite their high willingness to be 
vaccinated after receiving information about the flu vaccine, 
the vaccination coverage in pregnant women studied is still 
low and can be improved. Health professionals need new 
information strategies to extend vaccine uptake to a larger 
number of pregnant women in Spain. Midwife advice plays 
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sectional study was performed among pregnant women 
who gave birth in the three referral hospitals of the health 
departments under study (LR, TV and EC) between October 
20, 2014 and January 31, 2015. These hospitals provide health 
care to a total of 570,000 inhabitants (250,000 in LR; 170,000 
in TV and 150,000 in EC).
Once the total sample of pregnant women having given 
birth during the study period was obtained, their vaccination 
uptake was determined based on the Nominal Vaccination 
Registry (NVR).
The NVR portal was set up by the autonomous government 
and it electronically stores information on people vaccinated 
in hospitals, health centres and clinics in the Valencian 
Community since 1994 [12].
To analyse vaccination coverage and factors influencing 
vaccination, the following variables were used: health 
department (LR / TV / EC), age (<25 years, between 25 and 35 
years,> 35 years), country of origin (Spain, Others), parity (1 
child, 2 children, >3 children) and influenza vaccination status 
(yes/no/no data in NVR) during the 2014-15 season.
To identify the degree of knowledge, sources of 
information and attitudes towards the immunization of 
pregnant women, a subgroup of 100 pregnant vaccinated 
women and a subgroup of 100 non-vaccinated women were 
selected within each department. Inclusion in these two 
subgroups was determined randomly from among the studied 
population, in order to identify possible differences between 
them, with a level of significance of <0.05. The subgroup of 
vaccinated pregnant women did not reach the minimum 
sample of 100 women in two health departments (TV, 49 and 
55, EC) due to a lack of records in the NVR or because of its 
low vaccination coverage.
The study was conducted according to the Declaration 
of Helsinki and current legislation and was approved by 
the Research Commission of the participating centres 
after obtaining authorization from the Spanish Agency of 
Medicinal Products and Medical Devices (“Agencia Española 
del Medicamento y Productos Sanitarios”, AEMPS) (number 
CI2015-20).
Both subgroups were interviewed by telephone using a 
closed ad hoc survey, a survey conducted by authors of the 
current manuscript published in similar studies [14]. Telephone 
calls were made between March and May 2015, respondents 
were informed about confidentiality, protected anonymity, as 
well as the right not to answer questions.
 We asked vaccinated women about the source of the 
information of influenza vaccine, the health provider involved 
in recommending the vaccination, and whether they would 
opt to be vaccinated again in their next pregnancy the 
health provider involved in recommending the vaccination, 
and whether they would be vaccinated again in their next 
pregnancy. For the group of women who did not receive 
vaccines, asked if they had heard about the vaccine and, if 
so, which healthcare provider recommended it, the reasons 
vacunarse después de recibir información sobre la vacuna 
contra la gripe, la cobertura de vacunación en mujeres 
embarazadas estudiadas es aún baja y puede mejorarse. Son 
necesarias nuevas estrategias de formación e información por 
parte de los profesionales sanitarios para obtener un mayor 
número de gestantes vacunadas. El consejo de la matrona es 
un factor esencial en la emisión de la información sobre la 
vacunación antigripal recibida por las gestantes estudiadas. 
Palabras claves: Gripe, Embarazo, Inmunización, Cobertura Vacunal, Vacu-
nación, Matrona, Profesionales Sanitarios.
BACKGROUND
Pregnant women present a higher number and increased 
severity of diverse infections [1, 2], making them especially 
vulnerable to influenza [3-5]. This disease is one of the main 
causes of hospitalization during any pregnancy trimester, as 
well as respiratory infection in children aged under one year 
[6, 7]. 
The need of pregnant women and newborns for 
immunological protection has led the World Health 
Organization (WHO) to recommend influenza vaccination 
in any trimester of pregnancy [8, 9]. This recommendation is 
supported by results showing a reduction in influenza in 70% 
of immunized women [10] demonstrating its efficacy and 
safety [11, 4] as well as extending its protection to infants of 
up to six months of age [8, 9].
Following the recommendations of the WHO, the 
Valencian Community (Spain) included pregnant women in the 
influenza risk group as from 2013 [12]. Spain does not have 
official influenza vaccination records in pregnant women and 
the few published studies that do exist reveal vaccine coverage 
rates below 40% [6, 13, 14]. This figure contrasts with data 
reported in the United States, where uptake in pregnant 
women rose to up to 70% following the 2009 influenza 
pandemic [15].
Fear of possible adverse effects was the most cited reason 
by pregnant women for avoiding influenza vaccination [16]. 
Health professionals have a key role in promoting 
immunization in pregnant women. However, it has been found 
that a significant percentage of this group is unaware that 
pregnant women are included in the risk group subject to 
vaccination [17]. 
The purpose of this study is to investigate influenza 
vaccination coverage among pregnant women in three Health 
Departments of the Valencian Community (Spain): La Ribera 
(LR), Torrevieja (TV) and Elx-Crevillent (EC) during the 2014-
15 season, and identify their degree of knowledge, sources 
of information and attitudes towards immunization against 
influenza.
METHODS
An observational, multicentre, descriptive and cross-
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software SPSS version 20.0. Quantitative and qualitative 
variables were expressed as absolute frequencies, mean and 
ratios. Vaccination coverage was calculated as the percentage 
of women vaccinated with respect to the total number of 
pregnant women, and their 95% confidence interval (CI) 
was calculated. The Chi-square test was used to analyse the 
statistical significance of differences in vaccine coverage 
percentages between the categories of variables. To evaluate 
the adjusted effect of age, parity, country of origin and health 
department variables on non-vaccination, multivariate logistic 
regression models were constructed, taking non-vaccination 
as a response variable and the rest as explanatory variables.
for vaccine rejection, their knowledge about the vaccine and 
whether they would have the vaccine given in their next 
pregnancy.
The inclusion criteria in the study consisted in being 
pregnant and cared for by the Primary Health Care centres, 
as well as being assisted with labour diagnosis in the health 
departments (LR, TV and EC). Women having given birth 
in other hospitals were excluded, as well as those with 
contraindications to influenza vaccination, occurrence of 
antenatal death or who refused the telephone survey.
Statistical analysis was performed using the statistical 
Figure 1 Flow chart of study
Pregnant women during
flu season 2014-15
La Ribera n= 577
Torrevieja n= 420
Elx-Crevillent n= 572
 N= 1569
Data No NVR (La Ribera)         n= 157
Data No NVR (Torrevieja)        n= 259
Data No NVR (Elx-Crevillent)  n= 219
Study sample of post-partum women
Vaccinated Women Survey
Vaccinated Women Survey
NON Vaccinated Women Survey
NON Vaccinated Women Survey
La Ribera n= 420
Torrevieja n= 161
Elx-Crevillent n= 353
 N= 934
La Ribera n= 100
Torrevieja n= 49
Elx-Crevillent n=55
 N= 204
La Ribera n= 100
Torrevieja n= 41
Elx-Crevillent n=49
 N= 190
La Ribera n= 100
Torrevieja n= 100
Elx-Crevillent n= 100
 N= 300
La Ribera n= 100
Torrevieja n= 90
Elx-Crevillent n= 95
 N= 285
Did not answer
0 - 0
8 - 10
6 - 5
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department stood out because it disposed of no recorded data 
on 61.7% of postpartum women (table 1). The final sample 
under study turned out not to be homogeneous across the 
different health departments (LR, 420 (44.9%); TV, 161 (17.2%); 
and EC, 353 (37.8%)). Vaccination coverage was 27.9% (n=261 
[CI 95%: 25.0-30.7]), with a higher coverage in LR, with 37.7% 
(n = 157) and TV, with 30.4% (n = 49) (table 2). 
RESULTS 
After applying the exclusion criteria (figure 1), a total 
of 934 patients were finally selected out of a total of 1.569 
postpartum patients. A total of 635 (40.4%) postpartum 
women were discarded from the study because they did not 
have any data recorded in the NVR. In this respect, the TV 
No NVR information NVR information
n % n % Total
Total 635 40.5 934 59.5 1,569
Health department 
La Ribera 157 27.2 420 72.8 577
Torrevieja 259 61.7 161 38.3 420
Elx-Crevillent 219 38.3 353 61.7 572
Country of Origin
Spain 374 34.2 724 65.8 1098
Not Spain 261 55.4 210 44.5 471
Paritya
1 158 30.7 356 69.3 515
2 224 40.5 329 59.5 553
3 or more 253 49.2 248 50.2 286
Age
<25 years 73 33.2 147 66.8 220
25-35 years 409 40.8 593 59.2 1002
>35 years 153 44.1 194 55.9 347
Table 1  Pregnant women according to study variables and data in 
the Nominal Vaccination Registry (NVR).
aTotal number of pregnancies, including the current pregnancy.
n Vaccinated women % IC95%
Total 934 261 27.9 [25.0-30.7]
Health department
La Ribera 420 157 37.4 [33.1-42.3]
Torrevieja 161 49 30.4 [23.3-37.5]
Elx-Crevillent 353 55 15.6 [11.8-19.4]
Country of origin
Spain 724 193 26.7 [23.5-29.9]
Not Spain 210 68 32.4 [26.1-38.7]
Paritya
1 357 96 27.8 [22.4-31.6]
2 329 93 28.3 [23.4-33.2]
3 or more 248 72 29.0 [23.3-34.6]
Age
<25 years 147 38 25.9 [18.8-32.9]
25-35 years 593 162 27.3 [23.7-30.8]
>35 years 194 61 31.4 [24.8-37.9]
Table 2  Influenza vaccination coverage among pregnant women 
during the 2014-15 season
aTotal number of pregnancies, including the current pregnancy.
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TV and EC respectively (table 3).
A total of 94.7% (n = 180 (95% CI: 91.5-97.8) received 
information on the influenza vaccine at their Primary 
Health Care Centre, and the LR and EC departments stood 
out with 98% (n = 98) and 96 % (N = 47) respectively. 
Midwives accounted for 83.7% of the total number of health 
professionals involved (n = 159 [95% CI: 78.4-88.9]) and 
played a major role in recommending the vaccine to pregnant 
women. The 96.8% of vaccinated pregnant women (n = 184 
[95% CI: 94.3-99.3]) would get vaccinated again if they got 
pregnant again during the seasonal period of the vaccination 
campaign (table 3). 
A total of 285 non-vaccinated pregnant women were 
contacted for the telephone survey, with a distribution of 
35.1% (N = 100), 31.6% (n = 90), and 33.3% (n = 95), in LR, TV 
and EC respectively. Of these, 67.7% (n = 193 [95% CI: 26.4-
73.1]) had heard of influenza vaccination during pregnancy, EC 
showing the lowest level of information with 45.3% (n = 43) 
(table 3). Midwives, with 44.6% (n = 127), were again the main 
source of information in all three departments studied (table 
3). 
The main arguments put forward for rejecting 
Spain was the country of origin accounting for 77.5% 
(n=724) of the sample, presenting vaccination coverage of 
26.7% (n = 193 [95% CI: 23.5-29.9]). The remaining 22.5% 
(n=210) were non-Spanish, with a coverage of 32.4% (n=68 
[CI 26.1-38.7]) (table 2). 
Concerning the parity variable, higher coverage was 
observed in multiparous pregnant women (> 3 children), 29.0% 
(n = 72 [95% CI: 23.3-32.9]). This result is inversely related to 
the distribution of the study’s population, since the number 
of first parity (38.1% (n = 356)) or Second parous (35.2% (n = 
329)) women predominated.
Women between 25 and 35 years represented 63.5% (n 
= 593) of the total, followed by 20.7% (n = 194) of pregnant 
women> 35 years. Vaccination coverage in the > 35 years 
group was highest, with 31.4% (n = 61 [95% CI: 24.8-37.9]); 
this data had a descending orientation, 27.3% (n=162) and 
25.9% (n=38), according to the established age segments 
(table 2). 
Out of a total number of 190 surveys carried out on 
vaccinated pregnant women aiming at identifying the degree 
of knowledge, attitudes and sources of information, 52.6% 
(n=100), 21.6% (n=41) and 25.8% (n=49) corresponded to LR, 
Pregnant women vaccinated Total (n=190) % CI (95%) Pregnant women not vaccinated Total (n=285) % CI (95%)
Have you heard of influenza vaccination during pregnancy?
SI 67.7 [62.3-73.1]
No 32.3 [26.9-37.7]
Where did you receive information?
Primary Care Centre 94.7 [91.5-97.8] Did not receive 31.9 [26.4-37.3]
Media 2.1 [0.1-4.1] Media 8.8 [5.5-12.1]
Private consultation 2.6 [0.3-4.8] Family/Friends 7.7 [4.6-10.8]
The pregnant woman is a health care 
professional
0.5 [0.0-1.5] At work 0.7 [0.0-1.6]
Who recommended the influenza vaccine?
Family doctor 7.9 [4.1-11.7] Midwife 44.6 [38.8-50.4]
Midwife 83.7 [78.4-88.9] Gynaecologist 0.4 [0.0-1.1]
Health care professional 1.6 [0.0-3.4] Primary Care doctor 2.1 [0.4-3.8]
Gynaecologist 4.2 [1.3-7.0] The pregnant woman is a health care 
professional
3.9 [1.6-6.1]
Other 4.2 [1.3-7.0]
If you became pregnant again at the same time of year, would you get 
vaccinated again?
If you became pregnant again at the same time of year, would you get 
vaccinated then?
Yes 96.8 [94.3-99.3] Yes 61.8 [56.1-67.4]
No 3.2 [0.7-5.7] No 31.6 [26.2-36.9]
Not sure 6.7 [3.8-9.6]
Table 3  Attitudes and information sources on influenza vaccination in pregnant women 
vaccinated and not vaccinated during the 2014-15 season
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recommended by the WHO. Vaccination coverage of 50% was 
obtained in the population with cardiac pathology, 43% in 
health professionals and 17.4% in pregnant women [18].
Although vaccination is an essential recommendation 
to prevent and combat maternal and neonatal morbidity [1], 
vaccination coverage of pregnant women was low, showing 
unequal behaviour across the three health departments under 
study. The EC department, with 15.6%, presented the lowest 
rates, a figure similar to the 17.4% obtained in the southern 
area of  Madrid during the 2004-05 season [6]. 
In Europe, data on vaccine coverage of pregnant women 
are disparate. A study conducted in Germany during the 2012-
13 season turned out a coverage of 15.9% [19], another in the 
UK showed a coverage between 14.9% and 21.6% during the 
2009-10 season [20] and in Belgium a rate of 42.8% for the 
2013-14 season [21] was found. These latter figures are similar 
to those in different areas of the United States (41%) during 
the same season [22]. 
Although they are far from acceptable, our results reveal 
higher coverage rates than those in other similar studies, such 
as those described in the Barcelona health department (5%) 
during the 2007-08 season [13]. 
The influenza surveillance program developed in the 
Valencian Community shows a progressive increase in the 
number of influenza vaccine doses administered to pregnant 
women compared to previous seasons (7.6%; 9.2% and 14.8% 
for season 2011-12; 2012-13 and 2013-14 respectively) [12, 
18, 23]. 
These reports do not give real figures on the total number 
of pregnant women, but they do provide an estimate, so this 
study allows updating the situation of influenza immunization 
in the group of pregnant women in the Valencian Community. 
Significantly, non-Spanish pregnant women had better 
vaccination coverage than Spanish pregnant women. 
Data relating to age and parity variables were similar 
across studied departments, presenting a pattern of higher 
vaccination rates in pregnant women who were elder and 
had previously been mothers. This result coincides with that 
revealed in a recent systematic review of studies predominantly 
in Europe and America. This latter review concludes that 
older ages of pregnant women, previous experiences and 
recommendations of medical staff were the most influential 
factors in the acceptance of the vaccine against seasonal 
influenza [24]. 
Vaccinated pregnant women reported receiving 
information on the vaccine at their health centre and their 
midwife recommending it. The bond of trust established 
between midwives and pregnant women during the months of 
pregnancy could explain these results [14]. In addition, these 
data coincide with a similar study conducted in London [25], 
where recommendation by midwives accounted for 76% of 
cases. However, at the international level, the family doctor is 
found to be the health professional having the greatest impact 
in recommending influenza vaccination [20, 26]. Almost all 
administration of the vaccine were: unawareness of the 
recommendation of influenza vaccination during the 
gestational period with 29.5% (n = 84 [95% CI: 24.2-34.8, 
EC data standing out with 44.2% (n = 42); and 25,6% (n=73 
[IC95%: 15,5-35,6], not considering it necessary as a preventive 
measure, especially in the LR department with a total of 39% 
(n=39) (table 4).
A total of 61.8% (n = 176 [95% CI: 56.1-67.4]) of 
unvaccinated pregnant women interviewed showed a 
predisposition to get vaccinated against influenza in the case 
of a new pregnancy. 
An analysis of the logistic regression model of the 
department, country of origin, age and parity (modelling 
the probability of non-vaccination) variables, showed that 
there was no statistically significant relationship between 
influenza vaccination and the rest of the variables, except 
for the department variable. The EC department showed 
worse vaccination coverage than the LR department, these 
differences being statistically significant and adjusted by the 
multivariate model.
Differences with the TV department were not significant, 
although this may be due to lack of data on pregnant women 
profiles in the NRV; the latter were significantly elder than 
those in the RN department, with a greater number of children 
and a much higher percentage of non-Spanish women. 
DISCUSSION 
Vaccination coverage registered in the Valencian 
Community during the 2014-15 season in the so-called 
risk groups was less than 80% of the immunization rates 
Pregnant women not vaccinated
Total
(n=285)
%
CI (95%)
Could you indicate your reason for refusal?
Unawareness 29.5 [24.2-34.8]
Not necessary 25.6 [15.5-35.6]
Not receiving information from a health worker 12.3 [8.5-16.1]
Giving birth soon 8.1 [4.9-11.3]
Fear of adverse effects 8.1 [4.9-11.3]
Not effective 6.7 [3.8-9.6]
Never get vaccinated 3.9 [1.6-6.1]
Advised against by doctor 2.8 [0.9-4.7]
Have a cold 2.1 [0.4-3.7]
Long waiting list 1.1 [0.0-2.3]
Table 4  Reason for influenza vaccine refusal in 
pregnant women not vaccinated during 
the 2014-15 season
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vaccinated pregnant women surveyed said that in the case of a 
new pregnancy, they would get vaccinated again. Nonetheless, 
the behaviour of unvaccinated pregnant women was uneven 
according to the department, where a higher percentage of 
pregnant women were located in EC and TV, with the intention 
of not being vaccinated again. One study identified a greater 
predisposition to immunization in women who had already 
been vaccinated prior to their pregnancy during other flu 
seasons [27]. 
Unawareness that influenza vaccination is recommended 
during pregnancy is the main reason vaccine administration is 
rejected, thus corroborating data from previous studies. [28]. 
Other arguments against vaccination were that of considering 
it as non-effective and non-essential, which is part of the 
perception of lack of scientific evidence about the efficacy and 
safety of the vaccine [18, 29, 30]. 
Nevertheless, the safety of the influenza virus vaccine in 
pregnant women has been evaluated in observational studies 
[31] and to date, there is no evidence of an increase in adverse 
effects such as late antenatal death, miscarriage or congenital 
malformations [32]. Nor is there any evidence that pregnant 
women immunized against influenza develop a greater 
number of adverse effects compared to those who are not 
pregnant and are vaccinated [33]. 
The importance of information strategies during the 
vaccination season highlights the key role that health 
professionals have in transmitting such information [34] 
in socio-sanitary contexts as disparate as the United 
Kingdom [35] or Pakistan [36]. However, in other studies, the 
effectiveness of these interventions to increase vaccination 
coverage is put into question, and health professionals in 
contact with pregnant women are recommended to verbalize 
the benefits of the vaccine for newborns [37]. In this line of 
research, the majority of studies was situated in North America 
and was published in 2011, as a consequence of the 2009 
influenza pandemic. From that year onwards, a decrease of 
interest in scientific literature can be observed on influenza 
vaccination among pregnant women [30]. 
The recent inclusion of the dTpa vaccine as a 
recommendation for pregnant women may improve 
adherence to influenza vaccination. Both can be administered 
simultaneously and are safe for the mother and the child [38]. 
The study has some limitations since pregnant women 
without data in the RVN have been excluded from the study. 
A greater participation of the health professionals in charge 
of the registration of vaccines in the RVN would imply a 
considerable improvement of the vaccination program.
Vaccination coverage among the studied population of 
pregnant women was low and could be improved. In order 
to reach higher coverage rates, new strategies are needed to 
encourage health professionals to inform pregnant women, 
minimize excessive self-confidence and perceptions of the 
vaccine as dispensable. Disseminating scientific evidence 
available on the risks of influenza and the safety of the 
influenza vaccine as a Public Health preventive measure 
is essential. In Spain, midwife advice is a crucial factor in 
transmitting information to pregnant women on the influenza 
vaccine.
Both vaccinated and non-vaccinated pregnant women 
are highly predisposed to accepting immunization against 
influenza in the case of a new pregnancy, and this fact 
reinforces the importance of communication strategies 
directed at this group. 
Finally, in the light of the lost records observed, the NVR 
should be used with caution when determining the vaccination 
status of pregnant women. The duty of professionals to record 
each vaccination should be reinforced.
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